Status:
RECRUITING
The Symani Restore Study
Lead Sponsor:
Jacobs institute
Conditions:
Moyamoya Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A research study for a neurosurgical procedure in adult patients with Moyamoya disease
Detailed Description
The purpose of this research is to assess the safety and effectiveness of the Symani Surgical System in adult patients with Moyamoya disease.
Eligibility Criteria
Inclusion
- Patients aged \>18.
- Moyamoya disease with minor to moderate symptoms requiring neurosurgical treatment.
- Patients agree to have the surgery and the anesthesia.
- Patients who voluntarily decide to participate in this study with the surgery performed with the aid of Symani and agree to sign the Informed Consent Form.
- \-
Exclusion
- Patients who have bleeding or coagulation disorders in the past or present.
- Any criteria that preclude prolonged anesthesia.
- Hemodynamically unstable neurological exam.
- Pressure dependent neurologic status.
Key Trial Info
Start Date :
September 20 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2027
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT07140731
Start Date
September 20 2025
End Date
September 1 2027
Last Update
October 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jacobs Institute
Buffalo, New York, United States, 14203